Assenagon Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $13.8K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $747K | Buy |
|
|||||
|
2022
Q3 | $4.63M | Sell |
|
|||||
|
2022
Q2 | $4.01M | Buy |
|
|||||
|
2022
Q1 | $5.07M | Buy |
|
|||||
|
2021
Q4 | $1.16M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $3.47M | Sell |
|
|||||
|
2020
Q4 | $6.82M | Hold |
|
|||||
|
2020
Q3 | $4.52M | Buy |
|
|||||
|
2020
Q2 | $631K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $4.71M | Buy |
|